Abstract
Left ventricular (LV) dilatation in volume overload of isolated mitral regurgitation (MR) is marked by increased adrenergic drive and loss of extracellular matrix (ECM). Because mast cells are increased throughout the course of MR and may promote ECM degradation, we hypothesized that β1‐receptor blockade (β1‐RB) + mast cell stabilization (MCS) attenuates LV remodeling after 4 months of canine MR. β1‐RB +/− MCS did not attenuate the 30% reduction in ECM induced by MR. Three‐dimensional (3‐D) magnetic resonance imaging showed a 75% increase in LV end‐diastolic volume and a 45% increase in LV 3‐D radius/wall thickness (R/T) in MR +/− β1‐RB vs. normals. MCS did not attenuate LV dilatation but improved LV end‐systolic (ES) volume and 3‐D LVES R/T, resulting in improved LV fractional shortening. β1‐RB + MCS prevented cardiomyocyte elongation caused by MR + β1‐RB alone and normalized Ca++ transients, which were decreased in MR alone. In addition, isoproterenol induced Ca++ transients were improved with MCS. LV peak + dP/dtmax was significantly decreased in MR + β1‐RB and normalized by MCS. β1‐ RB + MCS reversed cardiomyocyte elongation and improved LV chamber function compared to β1‐RB alone without improving ECM loss, suggesting that MCS has a direct effect on cardiomyocyte remodeling and function in isolated MR. Supported by NIH RO1 HL54816 and SCCOR P50HL077100.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
